Green Planet Bioengineering Co Ltd

FRC's fair value estimate for Green Planet Bioengineering Co Ltd, and the rating behind it. GPLB last traded at $0.02; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Green Planet Bioengineering Co Ltd. Starting points for Green Planet Bioengineering Co Ltd: beta -1.67 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Green Planet Bioengineering Co Ltd. Green Planet Bioengineering Co Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Green Planet Bioengineering Co Ltd. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Green Planet Bioengineering Co Ltd. Green Planet Bioengineering Co Ltd has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Green Planet Bioengineering Co Ltd valued side by side against its closest peers. Green Planet Bioengineering Co Ltd is measured against Shell Companies peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Green Planet Bioengineering Co Ltd, and how their positions are changing. At a $342,109 market value, institutional positions materially move Green Planet Bioengineering Co Ltd's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Green Planet Bioengineering Co Ltd executives and directors. Shares of Green Planet Bioengineering Co Ltd have traded between $0.01 and $0.70 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Green Planet Bioengineering Co Ltd. Green Planet Bioengineering Co Ltd is a $342,109 Financial Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Green Planet Bioengineering Co Ltd. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Green Planet Bioengineering Co Ltd. Coverage tracks Green Planet Bioengineering Co Ltd within Shell Companies (Financial Services). Press releases and market coverage, newest first.